Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Dermatol Online J ; 30(1)2024 Mar 15.
Article in English | MEDLINE | ID: mdl-38762861

ABSTRACT

Juvenile xanthogranuloma is the most frequent form of non-Langerhans cell histiocytosis in children. Clinically, it presents as well defined, yellowish papules that are typically located on the head, neck, upper trunk, and proximal region of the extremities. Although solitary lesions are the most common presentation, few cases of multiple juvenile xanthogranuloma have been described, more frequently associated with extracutaneous involvement. We report a 2-month-old girl with 22 cutaneous papules, clinically and histologically compatible with juvenile xanthogranulomas. Screening of visceral involvement was performed with no evidence of systemic disease. Identifying high-risk factors of systemic disease in patients with multiple juvenile xanthogranuloma is essential to perform an appropriate management of this entity.


Subject(s)
Xanthogranuloma, Juvenile , Humans , Xanthogranuloma, Juvenile/pathology , Xanthogranuloma, Juvenile/diagnosis , Female , Infant
2.
Photodiagnosis Photodyn Ther ; 44: 103820, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37788795

ABSTRACT

INTRODUCTION: Non-melanoma skin cancer within previously irradiated areas presents a common challenge, requiring innovative therapies. Complex scenarios, like XRT-induced basal cell carcinoma (BCC) or Gorlin's syndrome, often involve multiple synchronous tumor lesions where photodynamic therapy (PDT) offers a viable therapeutic alternative. CLINICAL CASE: We present the case of a 49-year-old male with a history of XRT for brain tumors. The patient was undergoing treatment for recurrent basal cell carcinomas (BCCs) in the right temporal irradiated area, unresponsive to conventional treatments. In the latest evaluation, the patient presented a nodular tumor and several peripheral superficial foci. Photodynamic therapy (PDT) was administered using methyl aminolevulinate 160 mg/g in cream (Metvix®) in two sessions spaced 7 days apart before surgery. The photosensitizer was applied 3 h before initiating PDT, and red light exposure was performed with the Aktilite© lamp (wavelength 630 nm, 100 mm distance, voltage 100 to 240 V, frequency 50 Hz, power 180 W) for 7 min. CONCLUSIóN: PDT with methyl aminolevulinate demonstrated efficacy as a neoadjuvant treatment in a case of multiple XRT-induced BCCs before surgery. PDT emerges as a valuable therapeutic alternative for multiple BCCs, particularly in non-responsive cases.


Subject(s)
Basal Cell Nevus Syndrome , Carcinoma, Basal Cell , Photochemotherapy , Skin Neoplasms , Male , Humans , Middle Aged , Photosensitizing Agents/therapeutic use , Neoadjuvant Therapy , Skin Neoplasms/pathology , Photochemotherapy/methods , Carcinoma, Basal Cell/drug therapy , Carcinoma, Basal Cell/radiotherapy , Carcinoma, Basal Cell/pathology , Aminolevulinic Acid/therapeutic use , Basal Cell Nevus Syndrome/drug therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...